These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cholinesterase studies with (R) (+)- and (S)(-)-5-(1,3,3-trimethylindolinyl)-N-(1-phenylethyl)carbamate. Lieske CN; Gepp RT; Maxwell DM; Clark JH; Broomfield CA; Blumbergs P; Tseng CC J Enzyme Inhib; 1992; 6(4):283-91. PubMed ID: 1284965 [TBL] [Abstract][Full Text] [Related]
3. New N,N-dimethylcarbamate inhibitors of acetylcholinesterase: design synthesis and biological evaluation. De Vita D; Pandolfi F; Ornano L; Feroci M; Chiarotto I; Sileno I; Pepi F; Costi R; Di Santo R; Scipione L J Enzyme Inhib Med Chem; 2016; 31(sup4):106-113. PubMed ID: 27594053 [TBL] [Abstract][Full Text] [Related]
4. Molecular recognition by acetylcholinesterase at the peripheral anionic site: structure-activity relationships for inhibitions by aryl carbamates. Lin G; Lai CY; Liao WC Bioorg Med Chem; 1999 Dec; 7(12):2683-9. PubMed ID: 10658572 [TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase and acetylcholinesterase inhibitory effects of carbamates and sulfamoylcarbamates. Göçer H; Akincioğlu A; Göksu S; Gülçin İ; Supuran CT J Enzyme Inhib Med Chem; 2015 Apr; 30(2):316-20. PubMed ID: 24964347 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and in vitro evaluation of substituted N-(2-phenylcyclopropyl)carbamates as acetyl- and butyrylcholinesterase inhibitors. Horáková E; Drabina P; Brož B; Štěpánková Š; Vorčáková K; Královec K; Havelek R; Sedlák M J Enzyme Inhib Med Chem; 2016; 31(sup3):173-179. PubMed ID: 27476673 [TBL] [Abstract][Full Text] [Related]
7. Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors. Więckowska A; Bajda M; Guzior N; Malawska B Eur J Med Chem; 2010 Dec; 45(12):5602-11. PubMed ID: 20926161 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors. Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and inhibitory properties of some carbamates on carbonic anhydrase and acetylcholine esterase. Yılmaz S; Akbaba Y; Özgeriş B; Köse LP; Göksu S; Gülçin İ; Alwasel SH; Supuran CT J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1484-91. PubMed ID: 26985691 [TBL] [Abstract][Full Text] [Related]
10. Syntheses and anticholinesterase activity of tetrahydrobenzazepine carbamates. Chen YL; Liston D; Nielsen J; Chapin D; Dunaiskis A; Hedberg K; Ives J; Johnson J; Jones S J Med Chem; 1994 Jun; 37(13):1996-2000. PubMed ID: 8027982 [TBL] [Abstract][Full Text] [Related]
12. Acetylcholinesterase inhibition by sulphur and selenium heterosubstituted isomers of N,N-diethylcarbamyl choline and carbaryl. Lindgren B; Lindgren G; Artursson E; Puu G J Enzyme Inhib; 1985; 1(1):1-11. PubMed ID: 3939750 [TBL] [Abstract][Full Text] [Related]
13. Lead optimization studies towards the discovery of novel carbamates as potent AChE inhibitors for the potential treatment of Alzheimer's disease. Roy KK; Tota S; Tripathi T; Chander S; Nath C; Saxena AK Bioorg Med Chem; 2012 Nov; 20(21):6313-20. PubMed ID: 23026084 [TBL] [Abstract][Full Text] [Related]
14. Investigation of salicylanilide and 4-chlorophenol-based N-monosubstituted carbamates as potential inhibitors of acetyl- and butyrylcholinesterase. Krátký M; Štěpánková Š; Vorčáková K; Vinšová J Bioorg Chem; 2018 Oct; 80():668-673. PubMed ID: 30059892 [TBL] [Abstract][Full Text] [Related]
15. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation. Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596 [TBL] [Abstract][Full Text] [Related]
16. Novel carbamate derivatives as selective butyrylcholinesterase inhibitors. Bajda M; Łątka K; Hebda M; Jończyk J; Malawska B Bioorg Chem; 2018 Aug; 78():29-38. PubMed ID: 29529519 [TBL] [Abstract][Full Text] [Related]
17. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives. Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635 [TBL] [Abstract][Full Text] [Related]
18. 3-Hydroxyquinuclidinium derivatives: synthesis of compounds and inhibition of acetylcholinesterase. Reiner E; Skrinjarić-Spoljar M; Dunaj S; Simeon-Rudolf V; Primozic I; Tomić S Chem Biol Interact; 1999 May; 119-120():173-81. PubMed ID: 10421451 [TBL] [Abstract][Full Text] [Related]
19. Ethynylphenyl carbonates and carbamates as dual-action acetylcholinesterase inhibitors and anti-inflammatory agents. Saxena J; Meloni D; Huang MT; Heck DE; Laskin JD; Heindel ND; Young SC Bioorg Med Chem Lett; 2015 Dec; 25(23):5609-12. PubMed ID: 26510670 [TBL] [Abstract][Full Text] [Related]